Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Tata Business Cycle Fund · Direct ✕HDFC Pharma and Healthcare Fund · Direct ✕

Growth of ₹10,000

Basics

Tata Business Cycle FundHDFC Pharma and Healthcare Fund
CategorySectoral / ThematicSectoral / Thematic
PlanDirectDirect
Fund houseTataHDFC
NAV₹20.3358₹23.6750
NAV date20 Nov 202620 Nov 2026
History5.3 years3.1 years
Expense ratio0.9%1.1%
Stars★★★★★★★★★★
Growth Score39.7094.50

Returns

Tata Business Cycle FundHDFC Pharma and Healthcare Fund
1 month+6.72%+12.97%
3 months−2.01%+7.13%
6 months+2.04%+17.84%
YTD−0.19%+33.73%
1 year−0.59%+32.20%
3 years (CAGR)+10.51%+30.70%
5 years (CAGR)+13.59%—
10 years (CAGR)——
Since launch+14.42%+31.83%

Risk

Tata Business Cycle FundHDFC Pharma and Healthcare Fund
Volatility16.3%15.8%
Downside volatility11.2%8.5%
Sharpe0.251.53
Sortino0.362.86
Calmar0.532.06
Return / risk0.641.95
Deepest fall−20.01%−14.91%
Days to recover—126
Below its high−6.70%+0.00%

Against benchmark

Tata Business Cycle FundHDFC Pharma and Healthcare Fund
Alpha−1.09%+7.54%
Beta0.980.97
R²93.8%85.0%
Up capture98.1%108.9%
Down capture104.4%71.0%
Tracking error4.1%6.1%
Information ratio−0.291.17
Treynor0.030.24

Consistency

Tata Business Cycle FundHDFC Pharma and Healthcare Fund
Best 1-year+57.65%+67.01%
Middle 1-year+10.46%+23.25%
Worst 1-year−10.31%+1.71%
1-year periods with a loss14.5%0.0%
Middle 3-year+19.67%+30.22%
Positive months63.9%72.2%
Best day+4.03%+3.18%
Worst day−7.35%−3.61%
Worst 5% day−1.61%−1.51%
Positive days56.6%58.3%
NAVs a year247247

SIP of ₹10,000 a month

Tata Business Cycle FundHDFC Pharma and Healthcare Fund
5-year XIRR+11.48%—
5-year value₹8,05,248—
3-year XIRR+3.79%+27.71%
1-year XIRR+3.00%+41.37%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth